Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 01:38PM ET
3.24
Dollar change
-0.28
Percentage change
-7.94
%
Index- P/E- EPS (ttm)-37.39 Insider Own5.18% Shs Outstand0.53M Perf Week-10.00%
Market Cap1.72M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float0.51M Perf Month-20.30%
Income-40.45M PEG- EPS next Q- Inst Own131.26% Short Float0.01% Perf Quarter-39.30%
Sales0.00M P/S- EPS this Y- Inst Trans- Short Ratio0.00 Perf Half Y-73.45%
Book/sh-0.42 P/B- EPS next Y- ROA-205.89% Short Interest0.00M Perf Year-93.80%
Cash/sh5.02 P/C0.65 EPS next 5Y- ROE-312.04% 52W Range2.85 - 55.10 Perf YTD-20.11%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-94.12% Beta-
Dividend TTM- Quick Ratio0.70 Sales past 5Y0.00% Gross Margin- 52W Low13.63% ATR (14)0.49
Dividend Ex-Date- Current Ratio0.70 EPS Y/Y TTM-83.42% Oper. Margin0.00% RSI (14)40.12 Volatility17.85% 12.15%
Employees5 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price1520.00
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q-123.64% Payout- Rel Volume0.69 Prev Close3.52
Sales Surprise- EPS Surprise84.62% Sales Q/Q- Earnings- Avg Volume57.88K Price3.24
SMA20-14.29% SMA50-15.87% SMA200-71.50% Trades Volume26,077 Change-7.94%
Date Action Analyst Rating Change Price Target Change
Sep-15-21Initiated Maxim Group Buy $11
Feb-26-24 07:00AM
Dec-04-23 09:00AM
Nov-28-23 09:00AM
Aug-14-23 04:29PM
Aug-10-23 08:46AM
09:00AM Loading…
Aug-07-23 09:00AM
Aug-03-23 08:00AM
Jul-31-23 08:00AM
Apr-10-23 04:30PM
Apr-05-23 01:00PM
Feb-27-23 08:30AM
Feb-23-23 07:30AM
Feb-22-23 04:30PM
Jan-25-23 08:45AM
Jan-17-23 08:00AM
08:30AM Loading…
Jan-05-23 08:30AM
Jan-04-23 08:30AM
Dec-29-22 08:30AM
Dec-23-22 08:00AM
Dec-20-22 02:11PM
Dec-16-22 09:00AM
Nov-30-22 05:00PM
Nov-21-22 08:30AM
Nov-15-22 12:37PM
08:00AM
Sep-26-22 08:30AM
Aug-22-22 08:30AM
Jul-27-22 08:30AM
Jul-21-22 08:00AM
Jul-18-22 08:30AM
04:05PM Loading…
Jun-22-22 04:05PM
Jun-14-22 04:15PM
May-31-22 08:30AM
May-02-22 08:00AM
Apr-29-22 06:32PM
Feb-17-22 08:30AM
Jan-31-22 08:00AM
Dec-28-21 11:00AM
Dec-15-21 08:15AM
Dec-12-21 06:06AM
Dec-10-21 05:15PM
Dec-06-21 08:15AM
Dec-01-21 02:45PM
02:26PM
Nov-22-21 08:30AM
Nov-18-21 08:15AM
Nov-03-21 12:06PM
Oct-26-21 08:30AM
Sep-30-21 08:30AM
Sep-20-21 08:00AM
Aug-30-21 08:30AM
Aug-24-21 08:30AM
Aug-19-21 09:00AM
08:10AM
Aug-02-21 08:00AM
Jul-29-21 08:00AM
Jul-28-21 08:15AM
Jul-20-21 08:00AM
Jul-12-21 09:51AM
Jul-07-21 08:00AM
Jun-28-21 08:15AM
08:00AM
Jun-10-21 09:12AM
Jun-01-21 08:00AM
May-28-21 08:00AM
May-21-21 04:45PM
Apr-20-21 08:00AM
Apr-19-21 05:00PM
Apr-14-21 08:15AM
Mar-26-21 08:30AM
Mar-25-21 08:30AM
Mar-24-21 08:30AM
Mar-08-21 01:30PM
Feb-24-21 04:00PM
Feb-19-21 09:00AM
Feb-17-21 12:00AM
Jan-11-21 08:00AM
Jan-05-21 02:50PM
Dec-03-20 11:08AM
Nov-24-20 10:00AM
Nov-23-20 08:30AM
Nov-17-20 08:00AM
Nov-10-20 11:46AM
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Woody James N.Chief Executive OfficerDec 15Buy0.1925,0004,70066,888Dec 18 04:15 PM
Feldmann MarcDirectorDec 15Sale0.1925,0004,700115,497Dec 18 04:15 PM
STEINMAN LAWRENCEDirectorJun 01Buy1.2318,00022,06848,129Jun 02 08:00 AM
McGovern Jr. Donald A.DirectorMay 31Buy1.1510,00011,47030,099Jun 01 08:00 AM
McGovern Jr. Donald A.DirectorMay 19Buy1.165,0005,80020,099May 22 08:00 AM
Woody James N.Chief Executive OfficerMay 18Buy1.0340,00041,20041,888May 18 04:40 PM
McGovern Jr. Donald A.DirectorMay 18Buy1.0510,00010,50015,099May 22 08:00 AM
Marrone Pamela GDirectorMay 18Buy1.067,0827,50712,469May 19 08:45 AM
Pamir OzanCFOMay 18Buy1.015,1625,2148,983May 19 08:30 AM